BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 19646182)

  • 1. Metabolic syndrome: collapsing under its own weight?
    Preiss D; Sattar N
    Diabet Med; 2009 May; 26(5):457-9. PubMed ID: 19646182
    [No Abstract]   [Full Text] [Related]  

  • 2. [Obesity, diabetes mellitus and metabolic syndrome: the implications for heart and the vascular system].
    Maisch B
    Herz; 2006 May; 31(3):185-8. PubMed ID: 16770553
    [No Abstract]   [Full Text] [Related]  

  • 3. [The polycystic ovary syndrome--metabolic consequences].
    Tan S; Hahn S; Janssen OE
    Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolic syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 Study.
    Pajunen P; Rissanen H; Härkänen T; Jula A; Reunanen A; Salomaa V
    Diabetes Metab; 2010 Nov; 36(5):395-401. PubMed ID: 20673644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic status, metabolic syndrome, and cardiovascular risk in children.
    Berenson GS; Agirbasli M; Nguyen QM; Chen W; Srinivasan SR
    Med Clin North Am; 2011 Mar; 95(2):409-17, ix. PubMed ID: 21281842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COPD and concomitant diseases].
    Dierkesmann R; Gillissen A; Köhnlein T; Lorenz J; Magnussen H; Morr H; Pfeifer M; Schultze-Werninghaus G; Steinkamp G; Taube C; Teschler H; Vogelmeier C; Worth H
    Pneumologie; 2009 Sep; 63(9):526-37. PubMed ID: 19750413
    [No Abstract]   [Full Text] [Related]  

  • 7. Gender differences in obesity related cardiovascular risk factors in Spain.
    Cordero A; León M; Andrés E; Ordoñez B; Laclaustra M; Grima A; Pascual I; Luengo E; Civeira F; Pocoví M; Alegría E; Casasnovas JA;
    Prev Med; 2009 Feb; 48(2):134-9. PubMed ID: 19038283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study.
    de Simone G; Devereux RB; Chinali M; Best LG; Lee ET; Galloway JM; Resnick HE;
    Diabetes Care; 2007 Jul; 30(7):1851-6. PubMed ID: 17440172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
    Haffner SM
    Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
    Ballantyne CM
    Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefinition of the metabolic syndrome--useful or creating illness?
    Anscombe R; Krebs J; Weatherall M; Harding SA
    N Z Med J; 2006 Dec; 119(1247):U2372. PubMed ID: 17195862
    [No Abstract]   [Full Text] [Related]  

  • 13. The metabolic syndrome.
    Garber AJ
    Med Clin North Am; 2004 Jul; 88(4):837-46, ix. PubMed ID: 15308381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiometabolic risk.
    Strobl DJ
    J Am Osteopath Assoc; 2009 May; 109(5 Suppl):ii-S1. PubMed ID: 19902588
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease risk factors, metabolic syndrome and obesity in an Iranian population.
    Kelishadi R; Gharipour M; Sadri GH; Tavasoli AA; Amani A
    East Mediterr Health J; 2008; 14(5):1070-9. PubMed ID: 19161079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 17. Clustering of cardiovascular risk factors among Omani adults.
    Al Riyami AA; Afifi M
    East Mediterr Health J; 2003; 9(5-6):893-903. PubMed ID: 16450519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.
    Smith SC; Haslam D
    Curr Med Res Opin; 2007 Jan; 23(1):29-47. PubMed ID: 17261236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women.
    Hu G; Qiao Q; Tuomilehto J; Balkau B; Borch-Johnsen K; Pyorala K;
    Arch Intern Med; 2004 May; 164(10):1066-76. PubMed ID: 15159263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
    Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
    J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.